PDE4 accounts for only 8% of total cAMP-hydrolytic activity in human hearts compared to 32-52% in rodent hearts, and its expression is significantly reduced in failing human hearts.
While PDE4 has a similar local role in cAMP signaling in rodent and human hearts, its inhibition has global effects only in rodents due to differing proportions of total cardiac PDE activity, explaining distinct pharmacological effects between species.
PDE4 isoenzymes are critical in the control of cAMP signaling in rodent cardiac myocytes. Ablation of PDE4 affects multiple key players in excitation-contraction coupling and predisposes mice to the development of heart failure. As little is known about PDE4 in human heart, we explored to what extent cardiac expression and functions of PDE4 are conserved between rodents and humans. We find considerable similarities including comparable amounts of PDE4 activity expressed, expression of the same PDE4 subtypes and splicing variants, anchoring of PDE4 to the same subcellular compartments and macromolecular signaling complexes, and downregulation of PDE4 activity and protein in heart failure. The major difference between the species is a fivefold higher amount of non-PDE4 activity in human hearts compared to rodents. As a consequence, the effect of PDE4 inactivation is different in rodents and humans. PDE4 inhibition leads to increased phosphorylation of virtually all PKA substrates in mouse cardiomyocytes, but increased phosphorylation of only a restricted number of proteins in human cardiomyocytes. Our findings suggest that PDE4s have a similar role in the local regulation of cAMP signaling in rodent and human heart. However, inhibition of PDE4 has 'global' effects on cAMP signaling only in rodent hearts, as PDE4 comprises a large fraction of the total cardiac PDE activity in rodents but not in humans. These differences may explain the distinct pharmacological effects of PDE4 inhibition in rodent and human hearts.
Richter et al. (Wed,) conducted a other in Idiopathic dilated cardiomyopathy (n=11). PDE4 expression and inhibition vs. Normal human hearts and rodent hearts was evaluated on PDE4 activity as a fraction of total PDE activity. PDE4 accounts for only 8% of total cAMP-hydrolytic activity in human hearts compared to 32-52% in rodent hearts, and its expression is significantly reduced in failing human hearts.